NASDAQ:PHVS

Pharvaris News Headlines

$17.25

+0.23 (+1.35%)

(As of 05/13/2022 03:59 PM ET)

Add

Compare

Today's Range: $17.25
▼
$18.00
50-Day Range: $16.35
▼
$18.63
52-Week Range: $13.14
▼
$23.00

Volume: 4,100 shs
Average Volume: 13,324 shs
Market Capitalization: $549.24 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: -0.42

Get Pharvaris News Delivered to You Automatically

Media Mentions By Week

Pharvaris Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHVS
News Sentiment
▼
0.37

0.48
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHVS Articles
This Week
▼
5

0
▲
PHVS Articles
Average Week

Pharvaris (NASDAQ:PHVS) News Headlines Today

Source

Source	Headline
	Pharvaris GAAP EPS of -€0.48 seekingalpha.com - May 13 at 9:04 PM
	Pharvaris Reports Q1 EPS of EUR ($0.48), Provides Business Highlights investing.com - May 11 at 1:14 PM
	Pharvaris Reports First Quarter 2022 Financial Results and Provides Business Highlights finance.yahoo.com - May 11 at 1:14 PM
	Pharvaris Appoints Joan Schmidt, J.D., as Chief Legal Officer finance.yahoo.com - May 11 at 1:14 PM
	Pharvaris to Participate in BofA Securities 2022 Healthcare Conference finance.yahoo.com - May 5 at 7:01 PM
	Companies Like Pharvaris (NASDAQ:PHVS) Are In A Position To Invest In Growth finance.yahoo.com - May 4 at 3:06 PM
	Pharvaris (NASDAQ:PHVS) Shares Gap Down to $18.00 americanbankingnews.com - May 1 at 3:44 AM
	Pharvaris to Participate in Upcoming April Investor Conferences finance.yahoo.com - April 6 at 4:56 PM
	Pharvaris GAAP EPS of -€0.41 seekingalpha.com - March 30 at 8:20 PM
	Pharvaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights finance.yahoo.com - March 29 at 8:27 AM
	Pharvaris bradykinin-mediated angioedema treatment granted FDA Orphan Drug status seekingalpha.com - March 18 at 8:15 PM

	Pharvaris to Participate in Upcoming March Investor Conferences finance.yahoo.com - March 3 at 4:27 PM
	Is Henry Schein (HSIC) Outperforming Other Medical Stocks This Year? finance.yahoo.com - February 25 at 2:29 PM
	Pharvaris to Participate in 11th Annual SVB Leerink Global Healthcare Conference finance.yahoo.com - February 9 at 8:44 AM
	Pharvaris N.V. Ordinary Shares (PHVS) nasdaq.com - January 20 at 8:18 PM
	Pharvaris Announces Changes to its Board of Directors finance.yahoo.com - December 7 at 9:25 AM
	Pharvaris Reports Third Quarter 2021 Financial Results and Provides Business Highlights finance.yahoo.com - November 10 at 1:11 PM
	We're Hopeful That Pharvaris (NASDAQ:PHVS) Will Use Its Cash Wisely finance.yahoo.com - November 2 at 3:02 PM
	Pharvaris to Participate in Upcoming September Investor Conferences finance.yahoo.com - September 3 at 9:38 AM
	Pharvaris Reports Second Quarter 2021 Financial Results and Provides Business Highlights finance.yahoo.com - July 30 at 8:32 AM
	Pharvaris to Present PHA121 Clinical Data for Oral Treatment of Hereditary Angioedema at the EAACI Annual Congress 2021 finance.yahoo.com - July 1 at 7:17 AM
	Bitcoin Holds Short-Term Support; Faces Resistance at $40K sg.finance.yahoo.com - June 13 at 12:31 PM
	Pharvaris Announces Annual Meeting of Shareholders finance.yahoo.com - June 11 at 8:06 AM
	Pharvaris Presents Pharmacokinetic and Pharmacodynamic Data for Oral PHA121, Under Development for the Treatment of HAE, at 12th C1 Inhibitor Deficiency and Angioedema Workshop finance.yahoo.com - June 4 at 8:22 AM
	Pharvaris Reports First Quarter 2021 Financial Results and Provides Business Highlights finance.yahoo.com - May 26 at 10:06 AM
	Pharvaris Appoints Wim Souverijns, Ph.D., as Chief Community Engagement & Commercial Officer finance.yahoo.com - May 12 at 10:56 AM
	What Type Of Shareholders Own The Most Number of Pharvaris B.V. (NASDAQ:PHVS) Shares? finance.yahoo.com - May 6 at 4:56 PM
	We're Hopeful That Pharvaris B.V (NASDAQ:PHVS) Will Use Its Cash Wisely nasdaq.com - May 6 at 11:56 AM
	Pharvaris Reports Full Year 2020 Financial Results and Provides Business Highlights finance.yahoo.com - April 30 at 1:50 AM
	Pharvaris Announces FDA Acceptance of IND Application for Prophylactic Treatment of HAE Using PHVS416 finance.yahoo.com - April 21 at 12:26 PM
	Pharvaris Announces Closing of Initial Public Offering finance.yahoo.com - March 9 at 9:33 AM
	Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment of HAE, at the AAAAI Annual Meeting finance.yahoo.com - March 9 at 9:33 AM
	Pharvaris Doses First Patient in RAPIDe-1, a Phase 2 Study Evaluating PHVS416 for the On-Demand Treatment of HAE finance.yahoo.com - March 9 at 9:33 AM
	Pharvaris to Participate in BioCapital Europe finance.yahoo.com - March 9 at 9:33 AM

Get Pharvaris News Delivered to You Automatically

This page was last updated on 5/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources